← Leaderboards
John W Park
University Of California San Francisco
$3,200,648
Attributed
$3,200,648
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $438.5K · FY2005–12$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$3,200,648 · 5
By mechanism
P50$2,804,634 · 3
U54$316,544 · 1
R03$79,470 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California San Francisco
Same institution · by research overlap
- Karla M Kerlikowske$18,081,417
- Elliott P Vichinsky$12,339,152
- Kevin M Shannon$44,683,939
- Susan J. Fisher$38,160,909
- Laura J Esserman$22,971,436
Others in their field
Top investigators on “Clinical Trials”
- Lawrence Corey · Fred Hutchinson Cancer Center$824,102,536
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$622,583,125
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$542,008,718
- Bambra Strokes · Ppd Development Lp$526,656,217
- Judith S. Currier · University Of California Los Angeles$504,273,077
Research focus
Clinical TrialsTissuesMalignant NeoplasmsCollaborationsDrug Delivery SystemsMalignant Breast NeoplasmProgramsDoxorubicinLiposomesReceptorTranslationsResponseSeriesLeadLinkGene ExpressionTissue /Cell CultureMonoclonal AntibodyAntibodiesCancer CellCancer Cell LineAnthracyclinesBacteriophagesAdvocate
Grant awards (20)
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$327,264
P50 · FY2012 · CA · contact PI
Advocacy Core$111,252
P50 · FY2012 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$263,974
P50 · FY2011 · CA · contact PI
Advocacy Core$89,843
P50 · FY2011 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$320,140
P50 · FY2010 · CA · contact PI
Advocacy Core$108,162
P50 · FY2010 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$304,459
P50 · FY2009 · CA · contact PI
Advocacy Core$102,094
P50 · FY2009 · CA · contact PI
Lipidic Nanoparticle Drugs against Agressive Breast Cancer Subtypes$213,344
P50 · FY2008 · CA · contact PI
Advocacy Core$71,458
P50 · FY2008 · CA · contact PI
Development of novel therapeutics for brain tumor$188,006
P50 · FY2006 · CA · contact PI
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$158,272
U54 · FY2006 · CA · contact PI
Development of novel therapeutics for brain tumor$183,165
P50 · FY2005 · CA
Development of novel therapeutics for brain tumor$178,464
P50 · FY2004 · CA
Development of novel therapeutics for brain tumor$173,901
P50 · FY2003 · CA
Development of novel therapeutics for brain tumor$169,108
P50 · FY2002 · CA
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$158,272
U54 · FY2002 · CA
ANTIERBB2 ANTIBODY INDUCED PROTEIN INTERACTIONS$39,800
R03 · FY2001 · TW
CHARACTERIZATION AND PROFILING OF MICROMETASTASES$0
U54 · FY2001 · CA
ANTIERBB2 ANTIBODY INDUCED PROTEIN INTERACTIONS$39,670
R03 · FY2000 · TW